AACR Annual Meeting 2026

A new drug targeting triple-negative breast cancer overwhelms cancer cells with fat-like molecules called ceramides

Check out highlights from the UF Health Cancer Institute's participation at the AACR Annual Meeting.

UF Health Cancer Institute researchers aim to identify a new therapy that can improve overall ovarian cancer survival.

UF Health Cancer Institute researchers have created a novel drug that shows promise for the treatment of aggressive AML.

The findings could be used to identify women who might be at greater risk of stromal changes that could increase their breast cancer risk.

The gut microbiota drives changes to the immune system caused by chronic sleep loss, the study found.

UF researchers report evidence of differences in gene regulation based on ancestry.

For the first time, researchers have performed comprehensive genomic profiling of angiosarcoma cells.